These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 23218768)

  • 21. Deep brain stimulation for gait and postural symptoms in Parkinson's disease.
    Pötter-Nerger M; Volkmann J
    Mov Disord; 2013 Sep; 28(11):1609-15. PubMed ID: 24132849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication and subthalamic nucleus deep brain stimulation similarly improve balance and complex gait in Parkinson disease.
    McNeely ME; Earhart GM
    Parkinsonism Relat Disord; 2013 Jan; 19(1):86-91. PubMed ID: 22885253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study.
    Ricchi V; Zibetti M; Angrisano S; Merola A; Arduino N; Artusi CA; Rizzone M; Lopiano L; Lanotte M
    Brain Stimul; 2012 Jul; 5(3):388-392. PubMed ID: 21824834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postural instability and gait disorders after subthalamic nucleus deep brain stimulation in Parkinson's disease: a PET study.
    Ahrweiller K; Houvenaghel JF; Riou A; Drapier S; Sauleau P; Haegelen C; Jannin P; Vérin M; Palard X; Le Jeune F
    J Neurol; 2019 Nov; 266(11):2764-2771. PubMed ID: 31350641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of caudal pedunculopontine nucleus stimulation on postural instability and gait disorders in Parkinson's disease.
    Yu K; Ren Z; Hu Y; Guo S; Ye X; Li J; Li Y
    Acta Neurochir (Wien); 2022 Feb; 164(2):575-585. PubMed ID: 35029762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pedunculopontine Nucleus Deep Brain Stimulation Improves Gait Disorder in Parkinson's Disease: A Systematic Review and Meta-analysis.
    Lin F; Wu D; Lin C; Cai H; Chen L; Cai G; Ye Q; Cai G
    Neurochem Res; 2020 Apr; 45(4):709-719. PubMed ID: 31950450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of high-frequency subthalamic neurostimulation on gait and freezing of gait in Parkinson's disease: a systematic review and meta-analysis.
    Schlenstedt C; Shalash A; Muthuraman M; Falk D; Witt K; Deuschl G
    Eur J Neurol; 2017 Jan; 24(1):18-26. PubMed ID: 27766724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep Brain Stimulation of Pedunculopontine Nucleus for Postural Instability and Gait Disorder After Parkinson Disease: A Meta-Analysis of Individual Patient Data.
    Wang JW; Zhang YQ; Zhang XH; Wang YP; Li JP; Li YJ
    World Neurosurg; 2017 Jun; 102():72-78. PubMed ID: 28279773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amantadine improves gait in PD patients with STN stimulation.
    Chan HF; Kukkle PL; Merello M; Lim SY; Poon YY; Moro E
    Parkinsonism Relat Disord; 2013 Mar; 19(3):316-9. PubMed ID: 23218842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson's disease: a quantitative study.
    Vallabhajosula S; Haq IU; Hwynn N; Oyama G; Okun M; Tillman MD; Hass CJ
    Brain Stimul; 2015; 8(1):64-75. PubMed ID: 25440578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D visual cueing shortens the double support phase of the gait cycle in patients with advanced Parkinson's disease treated with DBS of the STN.
    Poláková K; Růžička E; Jech R; Kemlink D; Rusz J; Miletínová E; Brožová H
    PLoS One; 2020; 15(12):e0244676. PubMed ID: 33382785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study.
    Valldeoriola F; Muñoz E; Rumià J; Roldán P; Cámara A; Compta Y; Martí MJ; Tolosa E
    Parkinsonism Relat Disord; 2019 Mar; 60():153-157. PubMed ID: 30241951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.
    Hill EJ; Mangleburg CG; Alfradique-Dunham I; Ripperger B; Stillwell A; Saade H; Rao S; Fagbongbe O; von Coelln R; Tarakad A; Hunter C; Dawe RJ; Jankovic J; Shulman LM; Buchman AS; Shulman JM
    Parkinsonism Relat Disord; 2021 Mar; 84():105-111. PubMed ID: 33607526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Relevance of Standardized Mobile Gait Tests. Reliability Analysis Between Gait Recordings at Hospital and Home in Parkinson's Disease: A Pilot Study.
    Gaßner H; Sanders P; Dietrich A; Marxreiter F; Eskofier BM; Winkler J; Klucken J
    J Parkinsons Dis; 2020; 10(4):1763-1773. PubMed ID: 32925099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyses of the clinical factors and freezing of gait in association with the quality-of-life indexes in Parkinson's disease subjects with and without STN-DBS therapy.
    Onder H; Dilek SS; Bahtiyarca ZT; Comoglu S
    Neurol Res; 2024 Mar; 46(3):207-212. PubMed ID: 37856692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term evaluation of gait initiation in six Parkinson's disease patients with bilateral subthalamic stimulation.
    Muniz AM; Nadal J; Lyons KE; Pahwa R; Liu W
    Gait Posture; 2012 Mar; 35(3):452-7. PubMed ID: 22154114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease.
    Di Lazzaro G; Ricci M; Al-Wardat M; Schirinzi T; Scalise S; Giannini F; Mercuri NB; Saggio G; Pisani A
    J Parkinsons Dis; 2020; 10(1):113-122. PubMed ID: 31594252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of deep brain stimulation randomized by site on balance in Parkinson's disease.
    St George RJ; Carlson-Kuhta P; Nutt JG; Hogarth P; Burchiel KJ; Horak FB
    Mov Disord; 2014 Jun; 29(7):949-53. PubMed ID: 24532106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.
    Stefani A; Lozano AM; Peppe A; Stanzione P; Galati S; Tropepi D; Pierantozzi M; Brusa L; Scarnati E; Mazzone P
    Brain; 2007 Jun; 130(Pt 6):1596-607. PubMed ID: 17251240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.